This is a StreetInsider.com Premium Only Page

Sunesis Pharmaceuticals (SNSS) – StreetInsider.com Reports

Feb 23, 2021 01:21 AM Oppenheimer Upgrades Sunesis Pharmaceuticals Inc. (SNSS) to Outperform

Feb 16, 2021 08:02 AM Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma (SNSS)

Dec 7, 2020 08:35 AM Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA (SNSS)

Nov 30, 2020 07:32 AM Sunesis Pharmaceuticals (SNSS) and Viracta Therapeutics to Merge in All-Stock Transaction

Sep 2, 2020 12:48 PM Sunesis Pharmaceuticals (SNSS) Announces 1-for-10 Reverse Stock Split

Jul 29, 2020 09:07 AM Sunesis Pharmaceuticals (SNSS) Prices 52.17M Share Common Offering at $0.23/Sh

Jul 28, 2020 04:16 PM Sunesis Pharmaceuticals (SNSS) Announces Proposed Public Offering of Common Stock

Jul 7, 2020 04:02 PM Sunesis Pharmaceuticals (SNSS) reduces workforce to focus on development of PDK1 inhibitor, SNS-510

Jun 23, 2020 05:04 PM Oppenheimer Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Perform

Jun 23, 2020 09:26 AM Pre-Open Stock Movers 06/23: (TBIO) (APYX) (PTN) Higher; (SNSS) (SINT) (LK) Lower (more...)

Jun 23, 2020 07:43 AM Sunesis Pharmaceuticals (SNSS) to Resume Trading at 8 am

Jun 23, 2020 07:32 AM Sunesis Pharmaceuticals (SNSS) will not advance its non-covalent BTK inhibitor vecabrutinib into planned Phase 2 portion of Phase 1b/2 trial in CLL

Jun 23, 2020 07:27 AM Sunesis Pharmaceuticals (SNSS) Halted, News Pending

Mar 11, 2020 09:29 AM Pre-Open Movers 03/11: (INO) (GNMK) (HEAR) Higher; (LPI) (CDMO) (SNSS) Lower (more...)

Mar 11, 2020 07:41 AM Sunesis Pharmaceuticals Inc. (SNSS) PT Raised to $1 at H.C. Wainwright

Mar 11, 2020 04:29 AM Wells Fargo Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Equal Weight

Dec 9, 2019 07:59 AM Sunesis Pharmaceuticals Inc. (SNSS) PT Lowered to $3 at Wells Fargo

Dec 5, 2019 11:46 AM Sunesis Pharmaceuticals (SNSS) Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies

Nov 7, 2019 06:06 AM Sunesis Pharmaceuticals Inc. (SNSS) PT Lowered to $4 at Wells Fargo

Sep 19, 2019 07:05 AM Sunesis Pharmaceuticals (SNSS) Announces Dr. Nicole Onetto to Board

Jul 11, 2019 08:55 AM Pre-Open Movers 07/11: (IMUX) (OMER) (DVAX) (CI) (CVS) (WW) (SNSS) (BBBY) (FAST) (more...)

Jul 11, 2019 06:34 AM Sunesis (SNSS) Prices $25 Million Offering of Common Stock and Convertible Preferred Stock

Jul 10, 2019 05:13 PM After-Hours Movers 07/10: (DVAX) (AIR) (BBBY) (SNSS) (PSMT) (VSH)

Jul 10, 2019 04:04 PM Sunesis Pharmaceuticals (SNSS) Plans Public Offering of Common Stock and Preferred Stock

Jun 17, 2019 05:51 AM Sunesis Pharmaceuticals (SNSS) Presents Preliminary Data from Phase 1b/2 Trial of Vecabrutinib at EHA 2019 Meetings

Mar 8, 2019 01:13 PM Sunesis Pharmaceuticals Inc. (SNSS) PT Lowered to $6 at Oppenheimer, Stays Bullish

Mar 7, 2019 04:26 PM Sunesis Pharmaceuticals (SNSS) Tops Q4 EPS by 5c

Jan 18, 2019 05:37 AM Sunesis Pharmaceuticals (SNSS) Prices $20M Common & Preferred Share Offering

Jan 17, 2019 04:10 PM Sunesis Pharmaceuticals (SNSS) Announces Proposed Common & Preferred Share Offering

Jan 2, 2019 07:02 AM Sunesis Pharmaceuticals (SNSS) Reports Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib

Dec 20, 2018 07:51 AM UPDATE: H.C. Wainwright Starts Sunesis Pharmaceuticals Inc. (SNSS) at Neutral

Dec 3, 2018 06:01 AM Sunesis Pharmaceuticals (SNSS) Presents Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies

Nov 14, 2018 04:55 PM Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018

Jun 25, 2018 04:11 PM Sunesis Pharmaceuticals (SNSS) Reports $15.5M Common Stock Purchase Agreement with Aspire Capital

May 8, 2018 04:01 PM Sunesis Pharmaceuticals (SNSS) Tops Q1 EPS by 6c

Mar 9, 2018 01:41 AM Sunesis Pharmaceuticals Inc. (SNSS) PT Raised to $4 at Cantor Fitzgerald

Dec 11, 2017 09:17 AM Pre-Open Movers 12/11: (BLUE) (BPMC) (SNSS) Higher; (SYRS) (ONCE) (GBT) Lower (more...)

Dec 11, 2017 04:37 AM Wells Fargo Upgrades Sunesis Pharmaceuticals Inc. (SNSS) to Outperform Citing Positive BTK Data And ASH Expert Feedback

Dec 5, 2017 03:50 AM Wells Fargo Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Market Perform

Dec 4, 2017 04:12 PM Sunesis Pharmaceuticals (SNSS) Announces Daniel Swisher Resigned as CEO

Nov 30, 2017 07:03 AM Sunesis Pharmaceuticals (SNSS) Names William Quinn as CFO

Nov 21, 2017 09:21 AM UPDATE: Oppenheimer Starts Sunesis Pharmaceuticals Inc. (SNSS) at Outperform

Nov 21, 2017 09:09 AM Pre-Open Movers 11/21: (CLSN) (PANW) (SNSS) Higher; (CYTK) (QD) (SIG) Lower (more...)

Oct 25, 2017 09:06 AM Pre-Open Stock Movers 10/25: (MGNX) (AKAM) (LL) Higher; (ACHC) (CMG) (AMD) Lower (more...)

Oct 25, 2017 08:56 AM Sunesis Pharmaceuticals (SNSS) Prices of $20 Million Offering of Common Stock, Warrants

Oct 24, 2017 06:14 PM After-Hours Stock Movers 10/24: (AKAM) (WLL) (IRBT) Higher; (ACHC) (AMD) (CMG) Lower (more...)

Oct 24, 2017 04:09 PM Sunesis Pharmaceuticals (SNSS) to Offer Common Stock, Preferred Stock and Warrants

Jul 27, 2017 07:18 AM Sunesis Pharmaceuticals (SNSS) Posts Smaller-than-Expected Q2 Loss

Jun 23, 2017 07:11 AM Sunesis Pharmaceuticals (SNSS) Announces Presentation of Updated Results from Phase 1/Cohort Expansion Trial of Vosaroxin Plus Azacitidine in Patients with MDS at EHA

Jun 8, 2017 04:52 PM Sunesis Pharmaceuticals (SNSS) files $200 million mixed securities shelf